Course curriculum

    1. RAL Participant Directory

    1. Video: Federal Agencies: Impact on Rare Diseases

    2. FDA Organization Chart

    3. NIH Organization Chart

    4. NCATS Toolkit for Patient-Focused Therapy Development

    5. FDA's Patient-Focused Drug Development Glossary

    6. RDLA Glossary of Policy and Legislative Terms

    7. BIO Framework for the Use of Patient Experience Data Throughout the Product Lifecycle chart

    1. Agenda for Rare Advocacy Learning

    2. Rare Advocacy Learning Orientation Information

    1. Powerpoint Slides PDF of the Orientation

    2. Recording of the Orientation

    1. Agenda for Week 1: What is Patient Focused Drug Development?

    2. Recording for Week 1: What is Patient Focused Drug Development?

    3. Powerpoint slidedeck for Week 1: What is Patient Focused Drug Development?

    1. Recording for Week 2: Patient Engagement in Product Development: De-Risking the Development Space through PFDD--From Diagnostics to Data Resources

    2. Week 2 Quiz

    3. Agenda for Week 2: Patient Engagement in Product Development: De-Risking the Development Space through PFDD--From Diagnostics to Data Resources

    4. Powerpoint slides for Week 2: Patient Engagement in Product Development: De-Risking the Development Space through PFDD--From Diagnostics to Data Resources

About this course

  • Free
  • 30 lessons
  • 6 hours of video content

Discover your potential, starting today